Rating History for ZIOPHARM Oncology (ZIOP) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for ZIOP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/4/2014 N/A Upgrade Neutral
(Underweight)		 N/A
(N/A)		 4.21
(0.87)		 -79.33% Details